Financials
| Interim Results for the Six Months Ended 30 June 2023 | Sep. 27, 2023 |
| Arix Bioscience Plc - Annual Report & Accounts to 31 December 2022 | Apr. 25, 2023 |
| Financial Results for the Year Ended 31 December 2022, Publication of Annual Report & Notice of AGM | Apr. 25, 2023 |
| Interim Results for the Six Months Ended 30 June 2022 | Aug. 10, 2022 |
| Annual Report and Accounts FY2021 | May. 12, 2022 |
| Financial Results for the Year Ended 31 December 2021 | May. 05, 2022 |
| Arix Annual Report ESEF-T01 | Dec. 31, 2021 |
Proxies
| Correction: Result of Annual General Meeting | May. 24, 2023 |
| Result of Annual General Meeting | May. 23, 2023 |
| Arix Bioscience Plc - Notice of Annual General Meeting 2023 | Apr. 25, 2023 |
| Arix Bioscience Plc - Proxy form for AGM 2023 | Apr. 25, 2023 |
| ARIX Bioscience Plc, Special Business Resolutions passed at the Company's AGM | Jun. 07, 2022 |
| Result of Annual General Meeting 2022 | Jun. 07, 2022 |
| Publication of Annual Report & Notice of AGM | May. 12, 2022 |
Ownership Update
| Holding(s) in Company | Jan. 04, 2024 |
| PDMR Notification & Director Shareholding | Nov. 10, 2023 |
| PDMR Notification & Director Shareholding | Nov. 03, 2023 |
| PDMR Notification & Director Shareholding | Nov. 02, 2023 |
| Holding(s) in Company | Jul. 17, 2023 |
| Director/PDMR Shareholding | May. 31, 2023 |
| Director/PDMR Shareholding | May. 04, 2023 |
Announcements
| Arix Bioscience Plc - Results of 2nd General Meeting | Feb. 12, 2024 |
| Scheme Effective | Feb. 12, 2024 |
| Suspension of Trading in Shares | Feb. 12, 2024 |
| Transaction Update | Feb. 07, 2024 |
| Arix Bioscience Plc - Results of 1st General Meeting | Jan. 29, 2024 |
| Results of First General Meeting | Jan. 29, 2024 |
| Update on the Scheme and Publication of Notice of Second General Meeting | Jan. 23, 2024 |
Prospectuses
| Publication of Prospectus | Feb. 28, 2018 |
| Issuer Document | Feb. 02, 2017 |